Search

Your search keyword '"Verdecchia P"' showing total 61 results

Search Constraints

Start Over You searched for: Author "Verdecchia P" Remove constraint Author: "Verdecchia P" Topic humans Remove constraint Topic: humans
61 results on '"Verdecchia P"'

Search Results

1. Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project

2. Serum uric acid / serum creatinine ratio as a predictor of cardiovascular events. Detection of prognostic cardiovascular cut-off values

3. Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice:: GLORIA-AF Registry

4. The importance of including uric acid in the definition of metabolic syndrome when assessing the mortality risk

5. Relationships between diuretic related hyperuricemia and cardiovascular events: data from the URRAH (URic acid Right for heArt Health) study

6. Serum uric acid and fatal myocardial infarction: Detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study

7. [Hypertension after COVID-19 vaccination]

8. [Progress in the treatment of hypertension]

9. [ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus]

10. Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study

11. The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

12. Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: an overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists' Collaboration (BPLTTC)

13. Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years.

14. The management of acute venous thromboembolism in clinical practice. Results from the European PREFER in VTE Registry

15. Tight Versus Standard Blood Pressure Control in Patients With Hypertension With and Without Cardiovascular Disease

16. Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes

17. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

18. Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease

19. [Obesity and hypertension]

20. Prognostic value of serial electrocardiographic voltage and repolarization changes in essential hypertension: the HEART Survey study

21. Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk

22. [Arterial hypertension: an update]

23. Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial

24. [Ambulatory blood pressure monitoring in clinical practice]

25. Beta-blockers and arterial hypertension. Evidence-based medicine or excessive perseverance?]

26. [Antihypertensive therapy and cardiovascular prevention. The role of angiotensin II receptor blockers]

27. Prognostic Stratification of Patients With ST-Segment--Elevation Myocardial Infarction (PROSPECT): A Cardiac Magnetic Resonance Study.

28. Microalbuminuria and hypertension

29. Hypertrophy at ECG and its regression during treatment survey (HEART survey). Rationale, design and baseline characteristics of patients

30. Comparison of electrocardiographic criteria for diagnosis of left ventricular hypertrophy in hypertension: the MAVI study

31. Blood Pressure Monitoring. Task force III: Target-organ damage, morbidity and mortality

32. Prognostic value of combined echocardiography and ambulatory blood pressure monitoring in hypertensive patients at low or medium cardiovascular risk

33. Randomized study of traditional versus aggressive systolic blood pressure control (Cardio-Sis): rationale, design and characteristics of the study population

34. Serum uric acid levels threshold for mortality in diabetic individuals: The URic acid Right for heArt Health (URRAH) project

35. Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study

36. Identification of a plausible serum uric acid cut-off value as prognostic marker of stroke: the Uric Acid Right for Heart Health (URRAH) study

37. The association of uric acid with mortality modifies at old age: data from the uric acid right for heart health (URRAH) study

38. Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years

39. Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project

40. Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation. the GLORIA-AF registry

41. I stay at home with headache. A survey to investigate how the lockdown for COVID-19 impacted on headache in Italian children

42. Relative and Combined Prognostic Importance of On-Treatment Mean and Visit-to-Visit Blood Pressure Variability in ONTARGET and TRANSCEND Patients

43. Dabigatran etexilate: appropriate use in patients with chronic kidney disease and in the elderly patients

44. Persistence on apixaban in atrial fibrillation patients: a retrospective multicentre study

45. Echocardiography in Low-Risk Hypertensive Patients

46. Methodology and technology for peripheral and central blood pressure and blood pressure variability measurement: current status and future directions - Position statement of the European Society of Hypertension Working Group on blood pressure monitoring and cardiovascular variability

47. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring

48. Inappropriately high left ventricular mass in patients with type 2 diabetes mellitus and no overt cardiac disease. The DYDA study

49. Clinical value of ambulatory blood pressure: evidence and limits

50. Systolic and Diastolic Blood Pressure Changes in Relation With Myocardial Infarction and Stroke in Patients With Coronary Artery Disease

Catalog

Books, media, physical & digital resources